Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-21

Clinical Trial Update: Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69

View source ↗

Summary

A completed clinical trial describes an immune activation profile associated with insulin resistance in adults aged 55-69.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Insulin Resistance, Metabolic Syndrome X | Status: COMPLETED